Infectious Diseases News and Research

RSS

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

Telltale signs of concussions may be found in the gut, study suggests

A recently published study by Houston Methodist scientists suggests telltale signs of concussions might be found in the gut.

10 May 2022

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Annual cancer deaths in sub-Saharan Africa (SSA) could reach 1 million by 2030, nearly double the 520,000 deaths from cancer that occurred in 2020.

9 May 2022

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6).

9 May 2022

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

Researchers have been investigating the role of fomites in SARS-CoV-2 transmission.

9 May 2022

Evidence of croup associated with SARS-CoV-2

A new study published in the Journal of Pediatric Infectious Diseases Society aimed to characterize the clinical features of SARS-CoV-2-associated croup among children presenting to the ED during the phase when Omicron variant transmission was high.

9 May 2022

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).

6 May 2022

Study reveals why some lungs are protected against COVID

COVID-19 vaccines have saved at least a million lives in the United States alone, but for many people, a lingering fear remains: if - or when - they get hit by the coronavirus, just how bad will it be? Will they breeze through with little more than a sore throat - or will it saddle them with long-term complications, perhaps even push them to the brink of death?

6 May 2022

Crucial discovery could inform potential strategies to control malaria transmission

WEHI researchers in Melbourne have made a crucial discovery about how asymptomatic malaria infections impact the body, informing potential strategies to control transmission and improve treatment outcomes.

5 May 2022

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

Scientists have discussed the possibilities of developing oral replicon-based mRNA vaccines against SARS-CoV-2.

4 May 2022

The sensitivity of Omicron subvariants to therapeutic monoclonal antibodies

A new study evaluates the sensitivity of the new Omicron subvariants (BA.2.11, BA.2.12.1, and BA.4/5) to eight therapeutic mAbs

4 May 2022

How protection due to vaccination or previous SARS-CoV-2 infection varies for the population of the Czech Republic

The current study aimed to understand how far this reduced vaccine efficacy and the protection conferred by prior infection in terms of Omicron infection, hospitalization, and oxygen supplementation.

4 May 2022

Researchers investigate the population-level consequences of wearing masks

McMaster University researchers who study the dynamics of infectious disease transmission have investigated the population-level consequences of a potentially significant––and unobvious––benefit of wearing masks.

4 May 2022

Pets living in households with COVID-19 are high likely to seroconvert and become ill

In a recent study published in the journal Emerging Infectious Diseases, researchers investigated whether pet dogs and cats in the households of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected humans were at risk of infection.

3 May 2022

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

3 May 2022

Study offers insight into how remote learning impacts motivation of school students

Over 40% of parents of primary school students and 38% of parents of secondary school students felt their child found remote learning 'difficult' or 'very difficult', according to new data from the Schools Infection Survey (SIS).

3 May 2022

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

Researchers conducted epidemiologic and genomic studies to investigate in-flight SARS-CoV-2 infection associated with repatriation flights from India to Australia in April 2021.

3 May 2022

New technology to make temporary genetic modifications tested in mosquitoes

Texas A&M AgriLife Research scientists have tested a technology to make temporary genetic modifications in mosquitoes. The modifications self-delete over time.

3 May 2022

Antibiotics may disrupt microbiome to cause recurrent UTIs

A study by researchers at Washington University School of Medicine in St. Louis and the Broad Institute of MIT and Harvard suggests that women who get recurrent urinary tract infections (UTIs) may be caught in a vicious cycle in which antibiotics given to eradicate one infection predispose them to develop another.

2 May 2022

A “less is more” method may prevent antibiotic overuse in pediatric intensive care unit patients

When a patient in the pediatric intensive care unit (PICU) develops a fever, physicians often routinely order a blood culture to identify the cause, particularly if they have reason to worry about sepsis, a life-threatening condition that occurs when chemicals released by immune system cells in the bloodstream to fight an infection trigger inflammation and shock throughout the body.

2 May 2022

Infectious Diseases News and Research

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Telltale signs of concussions may be found in the gut, study suggests

Cancer mortality in sub-Saharan Africa could reach 1 million by 2030 without rapid interventions

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

Evidence of croup associated with SARS-CoV-2

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

Study reveals why some lungs are protected against COVID

Crucial discovery could inform potential strategies to control malaria transmission

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

The sensitivity of Omicron subvariants to therapeutic monoclonal antibodies

How protection due to vaccination or previous SARS-CoV-2 infection varies for the population of the Czech Republic

Researchers investigate the population-level consequences of wearing masks

Pets living in households with COVID-19 are high likely to seroconvert and become ill

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

Study offers insight into how remote learning impacts motivation of school students

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

New technology to make temporary genetic modifications tested in mosquitoes

Antibiotics may disrupt microbiome to cause recurrent UTIs

A “less is more” method may prevent antibiotic overuse in pediatric intensive care unit patients

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News